Semnur Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance
Semnur Pharmaceuticals, Inc. (SMNR) had Deferred Tax Assets, Valuation Allowance of $41.42 million as of 2025-12-31, per its S-1 filed 2026-05-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-05-12
- 2025-12-31: Deferred Tax Assets, Valuation Allowance $41.42M.
- 2024-12-31: Deferred Tax Assets, Valuation Allowance $17.36M.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2025-12-31 | $41.42M S-1 · filed 2026-05-12 |
| 2024-12-31 | $17.36M S-1 · filed 2026-05-12 |